Prostate Cancer. Malignant neoplasm of prostate, Carcinoma in situ: Prostate, Benign neoplasm: Prostate, ant neoplasm of prostate, Carcinoma in situ: Prostate, Benign neoplasm: Prostate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criterias: The age range of 45 to 59 years; The ability to speak and understand and write the Persian language; No history of attending similar educational programs; No history of prostate cancer screening; Non-participation in similar researches Exclusion criterias: Non-participation in one of the educational sessions; Withdrawing from the research
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prostate cancer screening behavior. Timepoint: Before and 8 weeks after intervention. Method of measurement: Researcher-made questionnaire.;Attitude toward prostate cancer screening behavior. Timepoint: Before and 8 weeks after intervention. Method of measurement: Researcher-made questionnaire.;Subjective norms of prostate cancer screening behavior. Timepoint: Before and 8 weeks after intervention. Method of measurement: Researcher-made questionnaire.;Perceived control of prostate cancer screening behavior. Timepoint: Before and 8 weeks after intervention. Method of measurement: Researcher-made questionnaire.;Behavioral intention of prostate cancer screening behavior. Timepoint: Before and 8 weeks after intervention. Method of measurement: Researcher-made questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences, School of Nursing and Midwifery